Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
10.95 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||
Net Income
| -133.816 | -121.755 | -78.996 | -36.168 | 46.383 | 71.956 | 17.71 | 21.666 | 78.992 | 34.438 | 9.627 | 21.399 | 23.31 | 7.904 |
Depreciation & Amortization
| 2.371 | 2.973 | 3.334 | 3.644 | 3.258 | 2.518 | 2.137 | 1.661 | 0.639 | 0.352 | 0.221 | 0.172 | 0.499 | 0.553 |
Deferred Income Tax
| -10.553 | 0 | 0.345 | 10.608 | -3.138 | 1.858 | -1.654 | -2.294 | 11.028 | -15.211 | 0.781 | 0 | -0.36 | 0 |
Stock Based Compensation
| 28.216 | 26.969 | 20.991 | 19.575 | 19.226 | 15.845 | 13.071 | 9.354 | 5.838 | 2.682 | 1.063 | 0.424 | 0.225 | 0.259 |
Change In Working Capital
| 8.024 | 6.789 | -13.688 | 12.9 | 11.491 | -61.787 | 21.97 | 6.171 | -16.83 | -2.258 | 0.741 | 0.093 | -2.4 | -18.411 |
Accounts Receivables
| 11.704 | 3.258 | -0.084 | 27.821 | 15.892 | -56.591 | 2.227 | 2.448 | -13.565 | -0.916 | 0.241 | -0.788 | -0.251 | -0.006 |
Inventory
| 0 | 0 | 0 | -16.3 | -6.483 | -6.421 | 18.632 | 1.875 | -3.371 | -1.731 | 0.37 | 0.096 | -1.393 | 1.555 |
Accounts Payables
| -1.151 | -4.634 | 3.774 | -0.883 | 1.791 | 1.317 | 0.633 | 1.451 | -0.543 | 0.399 | 0.115 | 0.763 | 0.058 | 0.181 |
Other Working Capital
| -10.553 | 8.165 | -17.378 | 2.262 | 0.291 | -0.092 | 0.478 | 0.397 | 0.649 | -0.01 | 0.015 | 0.022 | -0.814 | -20.141 |
Other Non Cash Items
| 2.604 | 0.242 | -1.982 | -3.471 | -5.802 | -1.17 | -0.581 | -0.749 | -2.994 | 0.176 | -1.78 | 0.535 | 2.745 | -0.48 |
Operating Cash Flow
| -103.154 | -84.782 | -69.996 | 7.088 | 71.418 | 29.22 | 52.653 | 35.809 | 76.673 | 20.179 | 10.653 | 22.623 | 24.019 | -10.175 |
Investing Activities: | ||||||||||||||
Investments In Property Plant And Equipment
| -9.058 | -2.125 | -0.75 | -1.445 | -5.417 | -2.981 | -2.506 | -4.738 | -2.336 | -1.028 | -0.606 | -0.252 | -0.445 | -0.037 |
Acquisitions Net
| 44.52 | -54.897 | -37.741 | -21.275 | 86.664 | 0 | 0 | 0 | 0.009 | 0 | 0 | 0.066 | 0.009 | 0 |
Purchases Of Investments
| -373.391 | -171.446 | -307.348 | -338.553 | -549.312 | -293.103 | -251.371 | -192.429 | -196.304 | -98.405 | -115.888 | -47.694 | -33.574 | -0.603 |
Sales Maturities Of Investments
| 328.871 | 228.468 | 345.089 | 359.828 | 468.065 | 260.682 | 249.305 | 153.504 | 110.617 | 99.927 | 47.278 | 28.7 | 16.764 | 2.303 |
Other Investing Activites
| -44.52 | 54.897 | 37.741 | 21.275 | -86.664 | -32.421 | -2.066 | -38.925 | -0.172 | 0.003 | -68.61 | 1.14 | -0.436 | 0 |
Investing Cash Flow
| -53.578 | 54.897 | 36.991 | 19.83 | -86.664 | -35.402 | -4.572 | -43.663 | -88.186 | 0.497 | -69.216 | -18.04 | -17.682 | 1.663 |
Financing Activities: | ||||||||||||||
Debt Repayment
| -199.675 | 0 | 0 | 0 | -0.086 | -0.079 | -0.073 | -0.068 | 0 | 0 | 0 | 0 | -2 | -0.007 |
Common Stock Issued
| 2.208 | 21.262 | 3.614 | 10.481 | 6.848 | 6.244 | 1.079 | 1.747 | 0 | 0 | 59.892 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | -1.229 | -0.534 | -1.498 | -4.188 | -1.756 | -0.202 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 198.126 | -1.229 | -0.534 | -1.498 | 2.66 | 4.488 | 1.09 | 2.773 | 2.54 | 1.164 | -2.981 | -0.909 | 2.034 | 0.015 |
Financing Cash Flow
| 198.126 | 20.033 | 3.08 | 8.983 | 2.574 | 4.409 | 1.017 | 2.705 | 2.54 | 1.164 | 56.911 | -0.909 | 0.034 | 0.008 |
Other Information: | ||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 41.394 | -9.852 | -29.925 | 35.901 | -12.672 | -1.773 | 49.098 | -5.149 | -8.973 | 21.84 | -1.652 | 3.674 | 6.371 | -8.504 |
Cash At End Of Period
| 89.356 | 47.962 | 57.814 | 87.739 | 51.838 | 63.902 | 65.675 | 16.577 | 21.726 | 30.699 | 8.859 | 10.511 | 6.837 | 0.466 |